Skip to content

A comparative study of biological and metabolic biomarkers between healthy individuals and patients with acne vulgaris

A comparative study of biological and metabolic biomarkers between healthy individuals and patients with acne vulgaris

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002212
Enrollment
100
Registered
2017-02-06
Start date
2017-05-11
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyung Hee University Oriental Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participation of the Population with Acne Vulgaris Participants who will meet the following criteria will be included: 1) Age of 19 to 35 years 2) Body mass index (BMI) of 18.5 to 23 kg/m2 3) Acne vulgaris [20 individuals with Korean Acne Grading System (KAGS) Gr 1 or 2; 20 individuals with KAGS Gr 3 or 4; and 20 individuals with over KAGS Gr 5) 4) Voluntary participation in this clinical trial Participation of the Healthy Controls Participants who will meet the following criteria will be included: 1) Age of 19 to 35 years 2) BMI of 18.5 to 23 kg/m2 3) No evidence of acne 4) (Only for women) Regular menstrual cycle during the last 3 months 5) No digestive-related uncomfortable symptoms in usual situations 6) No abdominal muscle tension 7) Other disorders that may affect the outcomes 8) Voluntary participation in this clinical trial

Exclusion criteria

Exclusion criteria: Participants who will meet any of the following will be excluded: 1) Use of oral steroids, oral contraceptives, oral vitamin A derivatives, antibiotics, or herbal medicines that may affect the test results during the last 4 weeks 2) No fasting for more than 8 hours after 9:00 pm on the day before the visit 3) Alcohol drinking within the last week 4) Smoking 5) Pregnancy or lactation 6) Judgment that physical or mental testing is not appropriate for the clinical trial 7) Participation in other clinical trials that may affect this trial

Design outcomes

Primary

MeasureTime frame
Molecular biological biomarker [1) Inflammatory indexes: 6 Cytokines related with the Inflammation(IL-1a, IL-1b, IL-12B, IL-15, IL-6, TNFa) and 2 Chemokines(MCP-1, IL-8) 2) Indexes related with the stress: Zinc, calcium, Corticotropin-releasing hormone(CRH) 3) Active oxygen: Reactive oxygen species(ROS)];Metabolism biomarker [1) The metabolic hormone related with Steroidogenesis or Testosterone such as DHEA(Dehydroepiandrosterone), Androstenedione, testosterone, DHT(Dihydrotestosterone), estrone, estradiol 2) Saturated and trans fats (palmitic acid, elaidic acid), amino acids and etc. 3) The targeted bio-markers and nontargeted bio-markers associated with the Tricarboxylic Acid Cycle];Skin bio-assessment [1) SM815 sebum measuring instrument 2) ST500 infrared light thermometer 3) RVM600 skin viscosity and elasticity measuring instrument];Questionnaire [1) Diet, Menstruation (female), contraceptive pill (female), family history, smoking, Sleep 2) The pattern Instrument of Acne(PIA)]

Countries

Korea, Republic of

Contacts

Public ContactSe Hyun Kang

Kyung Hee University Oriental Medical Center

kang8096@naver.com+82-2-958-9181

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 25, 2026